Nuvalent, Inc. (NUVL)

104.95 +2.83 (+2.77%) USD  |  NASDAQ  |  May 26, 16:00
104.89 -0.06 (-0.06%) After-Hours: 20:00
More

Nuvalent Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Cogent Biosciences, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
Vera Therapeutics, Inc. Upgrade
Tyra Biosciences, Inc. Upgrade